Articles From: Dice Holdings, Inc. Reports Third Quarter 2014 Results to Diebold and Banque Internationale a Luxembourg Integrate Mobile and ATM Channels To Offer Cardless Cash Withdrawal


NEW YORK , Oct.
Sign-up for Dice Holdings, Inc. Reports Third Quarter 2014 Results investment picks
NEW YORK , Nov.
Sign-up for Dice Holdings, Inc. to Present at Upcoming Investor Events investment picks
NEW YORK , Jan.
Sign-up for Dice Holdings, Inc. to Report Fourth Quarter and Full Year 2014 Results investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi therapeutics, today announced that the United States Patent and Trademark Office (USPTO) issued to Dicerna Patent No.
Sign-up for Dicerna Announces Issuance of US Patent Providing Broad Coverage of DsiRNA-EX RNAi Payloads investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of RNA interference (RNAi) therapeutics, today announced a licensing agreement for Dicerna to use Tekmira’s proprietary lipid nanoparticle (LNP) technology for delivery of DCR-PH1, Dicerna’s investigational product candidate for primary hyperoxaluria type 1 (PH1), a rare, inherited liver disorder that often results in kidney failure, and for which there are no approved therapies.
Sign-up for Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program investment picks
Dicerna Pharmaceuticals, Inc. (“Dicerna” or the “Company”) (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced the appointment of Theodore (Ted) T.
Sign-up for Dicerna Announces the Appointment of Theodore T. Ashburn, M.D., Ph.D. to Senior Vice President, Product Strategy and Operations, and Inducement Grant of Stock Options under NASDAQ Listing Rule 5635 (c)(4) investment picks
Dicerna Pharmaceuticals, Inc .
Sign-up for Dicerna Announces Third Quarter 2014 Financial and Operational Results investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi therapeutics, today announced the presentation of new preclinical data on its Dicer substrate short interfering RNA (DsiRNA) therapeutics targeting MYC and β-catenin (CTNNB1) oncogenes in models of hepatocellular carcinoma (HCC) and colorectal cancer (CRC). The positive data, presented during a poster session on January 9 at MYC: From Biology to Therapy, a meeting of the American Association of Cancer Research (AACR) in La Jolla, Calif., provide additional insights into the parameters that impact the delivery and activity of DsiRNA therapeutics utilizing Dicerna’s proprietary EnCore™ lipid nanoparticle (LNP) technology in HCC and CRC tumor models.
Sign-up for Dicerna Pharmaceuticals Presents Positive Preclinical Data on its DsiRNA Therapeutics Targeting MYC and β-Catenin at AACR MYC: From Biology to Therapy Meeting investment picks
Dicerna Pharmaceuticals, Inc .
Sign-up for Dicerna R&D Update Webcast Reminder investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNA interference (RNAi) based therapeutics, today announced that it will host its first R&D webcast to review the company’s strategy, technology, and expanding pipeline of innovative RNAi therapies.
Sign-up for Dicerna Reports on Progress of Development Programs investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that the Company will release its third-quarter 2014 financial results before market open on Thursday, November 6, 2014.
Sign-up for Dicerna to Announce Third-Quarter 2014 Financial Results and Host Conference Call on November 6, 2014 investment picks
Dicerna Pharmaceuticals, Inc .
Sign-up for Dicerna to Present at the 2014 Deutsche Bank BioFEST investment picks
Dicerna Pharmaceuticals, Inc .
Sign-up for Dicerna to Present at Two Upcoming Investor Conferences investment picks
2014/11/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G027155-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/24/11G027155/92a1d3d5c2a1c849_org-99501986.jpg WYOMISSING, PA--(Marketwired - November 24, 2014) - Richard A.
Sign-up for Dick Ehst, President and Chief Operating Officer of Customers Bank, Attends National Summit on Education investment picks
2014/11/20
Live Coverage of All Games on ESPN, ESPN2, ESPNU NEW YORK , Nov.
Sign-up for DICK'S High School Nationals Basketball Tournament Returns to New York City and Madison Square Garden investment picks
Special Appearance by Brian Orakpo PITTSBURGH , Oct.
Sign-up for DICK'S Sporting Goods Announces Grand Opening Celebration in Frederick, MD investment picks
Special Appearance by Jerry Kramer PITTSBURGH , Oct.
Sign-up for DICK'S Sporting Goods Announces Grand Opening Celebration in LaCrosse, WI investment picks
Special Appearance by Blair Wiggins PITTSBURGH , Oct.
Sign-up for DICK'S Sporting Goods Announces Grand Opening Celebration in Naples, FL investment picks
Special Appearance by Allan Houston PITTSBURGH , Oct.
Sign-up for DICK'S Sporting Goods Announces Grand Opening Celebration in Wayne, NJ investment picks
Special Appearance Saturday by Tom Herr PITTSBURGH , Oct.
Sign-up for DICK'S Sporting Goods Announces Grand Opening Celebration in Wentzville, MO investment picks
Shares of Dick's Sporting Goods inc.
Sign-up for Dick's Sporting Goods mulling going private: Reuters investment picks
Dick's Sporting Goods Inc. (DKS) said Tuesday it had net income of $49.2 million, or 41 cents a share, in the third quarter, down from $50 million, or 40 cents a share in the year-earlier period, dragged down by continued weakness in golf and hunting.
Sign-up for Dick's Sporting Goods profit dips on continued weak golf, hunting sales investment picks
- Consolidated earnings per diluted share totaled $0.41, at the higher end of guidance of $0.38 to 0.42 - Consolidated same store sales increased 1.1% - Company repurchased $75 million of common stock and declared a $0.125 per share quarterly dividend PITTSBURGH , Nov.
Sign-up for DICK'S Sporting Goods Reports Third Quarter Results investment picks
Dick's Sporting Goods Inc. (DKS) suffered two downgrades Friday, after running up in Thursday's session on a report the retailer is considering going private.
Sign-up for Dick's Sporting Goods suffers 2 downgrades after report it may go private investment picks
PITTSBURGH , Nov.
Sign-up for DICK'S Sporting Goods Third Quarter Results Call Scheduled for November 18th investment picks
Customers who purchased the item are encouraged to return it for a full refund PITTSBURGH , Jan.
Sign-up for DICK'S Sporting Goods Voluntarily Recalls Fitness Gear Inversion Table investment picks
2014/11/5
By David Weidner, MarketWatch SAN FRANCISCO (MarketWatch) -- Wall Street had a lot riding on this election.
Sign-up for Did Wall Street buy this election? investment picks
2009/08/07
While funds such as CGM Focus and Fairholme have raked in assets, many of their investors are late to the party.
Sign-up for Did You Do as Well as Your Fund? investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Dice Holdings, Inc. Reports Third Quarter 2014 Results to Diebold and Banque Internationale a Luxembourg Integrate Mobile and ATM Channels To Offer Cardless Cash Withdrawal
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent